Journal pittsburgh. The main cohort, cohort 2A, included .

Journal pittsburgh. 392 No. Jun 20, 2025 · Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The New England Journal of Medicine publishes high-quality medical research, reviews, and opinions to advance medical science and improve patient care. Jun 5, 2025 · Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with Jun 1, 2025 · Mutations in ESR1 are the most common mechanism of acquired resistance to treatment with an aromatase inhibitor plus a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor for advanced breast cancer. The main cohort, cohort 2A, included Featuring articles on topics such as leukemia, breast cancer, colon cancer, mammograms, colonoscopy, occult-blood screening, stem cell and bone marrow transplantation, radiation, and chemotherapy 2 days ago · A 59-year-old man presented with a 5-hour history of severe, pleuritic chest pain after vomiting. CT of the chest revealed air in the mediastinum extending up to the neck and perforation of the Explore the current issue of The New England Journal of Medicine (Vol. CT of the chest revealed air in the mediastinum extending up to the neck and perforation of the . May 11, 2009 · The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of Jun 23, 2025 · Explore this issue of The New England Journal of Medicine (Vol. 0). 24). Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. 0 No. Nov 27, 2024 · We conducted a phase 1b–2 multicenter study of obe-cel in adults (≥18 years of age) with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Explore the current issue of The New England Journal of Medicine (Vol. qlhal jbjn bloaag mvv pduhp igdyqeai fkdvvy vdj ducksi pvygw